CH

Optosys Sa

USPTO Granted Patents = 21

% Expired Patents = 23.8


Forward Citations = 80

Loading Chart...
Loading Chart...

10 inventors (with patents filed for the assignee):

goldMedal Peter Heimlicher (17 out of 19 patents)

silverMedal Charles Rhême (9 out of 10 patents)

bronzeMedal Roland Bochud (4 out of 4 patents)

4.  Annette Liggenstorfer-Heimlicher (2 out of 2 patents)

5.  Laurent Genilloud (2 out of 4 patents)

6.  Marc De Huu (2 out of 2 patents)

7.  Pierre-Yves Dénervaud (1 out of 1 patent)

8.  Philippe Venier (1 out of 1 patent)

9.  Fabrice Charriere (1 out of 1 patent)

10.  Johan Cuperus (1 out of 1 patent)

11.  Peter Heimlicher (1 patent)

12.  Jean Daniel Chatelain (0 patent)

13.  Fabrice Charrière (0 patent)


21 patents:

Company Overview
Optosys Sa is a Swiss company specializing in advanced optical systems and technologies. The organization focuses on the development and manufacturing of innovative solutions for various applications, including medical devices and industrial optics. With a commitment to research and development, Optosys Sa aims to enhance performance and efficiency in optical applications, leveraging cutting-edge technology to meet the evolving needs of its clients across diverse sectors. Its expertise positions it as a key player in the optical technology landscape.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Optosys Sa USPTO Patent Assignee Logo
21 Patents

#24 in

#593 in Switzerland

#30,001 in the World

CH
CH
Forward Citations = 80

10 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Optosys Sa. Retrieved from https://idiyas.com/company/optosys-sa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…